176 related articles for article (PubMed ID: 15701878)
1. Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Ingle JN; Arteaga CL; Brodie AM; Colditz GA; Johnston SR; Kristensen VN; Lønning PE; McDonnell DP; Osborne CK; Russo J; Santen RJ; Yee D; Hart CS
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):861s-4s. PubMed ID: 15701878
[No Abstract] [Full Text] [Related]
2. Selecting adjuvant endocrine therapy for breast cancer.
Eneman JD; Wood ME; Muss HB
Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
[TBL] [Abstract][Full Text] [Related]
3. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
[TBL] [Abstract][Full Text] [Related]
4. Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Arteaga CL; Bissell MJ; Brown MA; Ellis MJ; Goss PE; Green JE; Ingle JN; Lee AV; Medina D; Nicholson RI; Santen RJ; Schiff R; Hart CS
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-330S. PubMed ID: 14734487
[No Abstract] [Full Text] [Related]
5. [Hormone therapy for breast cancer].
Uramoto H; Kagami S; Iwashige A; Tsukada J
J UOEH; 2006 Sep; 28(3):287-94. PubMed ID: 16981405
[TBL] [Abstract][Full Text] [Related]
6. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
Jordan VC; Brodie AM
Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
[TBL] [Abstract][Full Text] [Related]
7. Management of choroidal metastases from breast carcinomas using aromatase inhibitors.
Manquez ME; Brown MM; Shields CL; Shields JA
Curr Opin Ophthalmol; 2006 Jun; 17(3):251-6. PubMed ID: 16794437
[TBL] [Abstract][Full Text] [Related]
8. Clinical review: Effect of endocrine therapies on bone in breast cancer patients.
Santen RJ
J Clin Endocrinol Metab; 2011 Feb; 96(2):308-19. PubMed ID: 21147884
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges.
Rej RK; Thomas JE; Acharyya RK; Rae JM; Wang S
J Med Chem; 2023 Jul; 66(13):8339-8381. PubMed ID: 37377342
[TBL] [Abstract][Full Text] [Related]
10. Proceedings of the 3rd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer.
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-409S; quiz i-iv. PubMed ID: 14981797
[No Abstract] [Full Text] [Related]
11. [Adjuvant endocrine therapy in premenopausal breast cancer].
Bando H
Nihon Rinsho; 2012 Sep; 70 Suppl 7():627-35. PubMed ID: 23350475
[No Abstract] [Full Text] [Related]
12. Endocrine therapy for breast cancer: an overview.
Cheung KL
Breast; 2007 Aug; 16(4):327-43. PubMed ID: 17499991
[TBL] [Abstract][Full Text] [Related]
13. [Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].
Lindberg H; Nielsen DL; Tuxen M; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3096-100. PubMed ID: 17877958
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen-receptor modulators in 2001.
O'Regan RM; Gradishar WJ
Oncology (Williston Park); 2001 Sep; 15(9):1177-85, 1189-90; discussion 1190-4. PubMed ID: 11589065
[TBL] [Abstract][Full Text] [Related]
15. [Advancement in endocrine therapy for breast cancer].
Yang MT; Lian ZQ
Ai Zheng; 2007 Apr; 26(4):440-4. PubMed ID: 17430670
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
Baumann CK; Castiglione-Gertsch M
Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
[TBL] [Abstract][Full Text] [Related]
17. To switch or not to switch: should the updated Intergroup Exemestane Study alter our decision?
Iddon J; Bundred NJ
Expert Rev Anticancer Ther; 2008 Jan; 8(1):9-13. PubMed ID: 18095878
[TBL] [Abstract][Full Text] [Related]
18. The endocrine prevention of breast cancer.
Howell A
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):615-23. PubMed ID: 18971122
[TBL] [Abstract][Full Text] [Related]
19. Intergroup Exemestane Study mature analysis: overall survival data.
Jassem J;
Anticancer Drugs; 2008 Feb; 19 Suppl 1():S3-7. PubMed ID: 18340242
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hormone-related cancers: breast cancer.
Dunn BK; Wickerham DL; Ford LG
J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
